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Abstract. 
 
Microtubule-associated protein 1B 
(MAP1B), one of the microtubule-associated proteins 
(MAPs), is a major component of the neuronal cyto-
skeleton. It is expressed at high levels in immature neu-
rons during growth of their axons, which indicates that 
it plays a crucial role in neuronal morphogenesis and 
neurite extension. To better define the role of MAP1B 
in vivo, we have used gene targeting to disrupt the mu-
rine MAP1B gene. Heterozygotes of our MAP1B dis-
ruption exhibit no overt abnormalities in their develop-
ment and behavior, while homozygotes showed a 
slightly decreased brain weight and delayed nervous 
system development. Our data indicate that while 
MAP1B is not essential for survival, it is essential for 
normal time course development of the murine nervous 
system. These conclusions are very different from those 
of a previous MAP1B gene–targeting study (Edelmann, 
W., M. Zervas, P. Costello, L. Roback, I. Fischer, A. 
Hammarback, N. Cowan, P. Davis, B. Wainer, and R. 
Kucherlapati. 1996. 
 
Proc. Natl. Acad. Sci. USA.
 
 93:
1270–1275). In this previous effort, homozygotes died 
before reaching 8-d embryos, while heterozygotes 
showed severely abnormal phenotypes in their nervous 
systems. Because the gene targeting event in these mice 
produced a gene encoding a 571–amino acid truncated 
product of MAP1B, it seems likely that the phenotypes 
seen arise from the truncated MAP1B product acting in 
a dominant-negative fashion, rather than a loss of 
MAP1B function.
T
 
he
 
 neuron is a highly polarized cell from which
characteristically long processes, the axons and den-
drites, extend. In these processes, the neuronal cy-
toskeleton acts as a dynamic scaffold composed of longitu-
dinally arranged neurofilaments (NFs)
 
1
 
 and microtubules
(MTs). MTs tend to form fascicles in which various kinds
of crossbridge structures have been observed (Hirokawa,
1982; Hirokawa et al., 1985).
Microtubule-associated proteins (MAPs), a group of fil-
amentous proteins such as microtubule-associated protein
1B (MAP1B), MAP1A, MAP2, and tau, have been dem-
onstrated to be components of these extensive crossbridge
structures associated with MTs (Hirokawa et al., 1985,
1988
 
a
 
,
 
b
 
; Shiomura and Hirokawa, 1987
 
a
 
,
 
b
 
; Sato-Yoshi-
take et al., 1989; Hirokawa, 1991). Considerable evidence
supports the hypothesis that MAPs play a crucial role in
neuronal morphogenesis. In fact, cDNA transfection stud-
ies have revealed that tau and MAP2 induce elongation of
processes of nonneuronal cells, such as fibroblasts and Sf9
cells, and formation of MT bundles (Kanai et al., 1989,
Lewis et al., 1989; Knops et al., 1991, Chen et al., 1992).
MAP1B, a major component of the neuronal cytoskele-
ton (Bloom et al., 1984, 1985), which is also known as
MAP1.2 (Greene et al., 1983), MAP1x (Calvert and Ander-
ton, 1985), and MAP5 (Riederer et al., 1986), forms long
crossbridges between MTs (Hirokawa et al., 1985; Sato-
Yoshitake et al., 1989). MAP1B is encoded by a single-
copy gene (Garner et al., 1990), the product of which is
proteolytically processed to a heavy chain and light chain 1
(LC1), which are assembled with LC2 and LC3 to form a
complex MT-binding domain (Vallee and Davis, 1983;
Hammarback et al., 1991). MAP1B is mainly expressed in
neurons, though it exists in other cell types as well (Fischer
et al., 1990; Vouyiouklis and Brophy, 1993; Ulloa et al.,
1994). MAP1B is expressed at high levels in the immature
nervous system, and its level of expression declines in par-
allel with neuronal differentiation (Bloom et al., 1985;
Lewis et al., 1986, Riederer et al., 1986; Safaei and Fischer,
1989; Schoenfeld et al., 1989; Tucker et al., 1989; Garner et
al., 1990). In the adult nervous system, MAP1B continues
to be expressed in localized brain areas, for example in ol-
factory nerve axons (Viereck et al., 1989) and retinal pho-
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tosensitive cells (Tucker and Matus, 1988) where axonal
elongation continues. Phosphorylation of MAP1B is also
under strong developmental control; that is, the level of
mode I phosphorylation catalyzed by proline-directed pro-
tein kinases decreases during development, but that of
mode II phosphorylation catalyzed by casein kinase II is
maintained in the mature nervous system (Avila et al.,
1994). Furthermore, several lines of in vitro evidence sug-
gest that MAP1B plays a role in neurite extension. Deple-
tion of casein kinase II, which is thought to catalyze phos-
phorylation of MAP1B (Díaz-Nido et al., 1988), blocked
neuritogenesis of mouse neuroblastoma cells (Ulloa et al.,
1993), and attenuation of MAP1B expression by antisense
oligonucleotide treatment resulted in inhibition of neurite
extension of NGF-treated PC12 cells (Brugg et al., 1993).
However, the function of MAP1B in vivo is still largely un-
known.
To define the function of MAP1B in vivo, we have dis-
rupted the MAP1B gene by homologous recombination in
embryonic stem (ES) cells and used these mutant cells to
generate mutant mice with a disrupted MAP1B allele
(R21). Mouse lines with mutations in the MAP1B gene
have been previously described (Map1b571) (Edelmann
et al., 1996), the phenotypes of which are very different
from those of R21. Edelmann et al. (1996) reported that
Map1b571 embryos homozygous for the mutated MAP1B
gene died before reaching 8-d embryos, and Map1b571
heterozygotes showed severely abnormal phenotypes such
as motor dysfunction, vast histological abnormalities, lack
of visual acuity, and premature mortality. However, in our
study, R21 heterozygotes exhibited no overt abnormalities
in their development and behavior. The size of the adult
R21 homozygous mutant brain was slightly reduced and
EM analysis revealed delayed development of the R21 ho-
mozygous mutant nervous system, though histological ab-
normalities reported by Edelmann et al. (1996), such as
abnormal morphology of the cerebellar Purkinje cells, were
not observed. A long truncated peptide produced by
Map1b571 mutants is considered to act in a dominant-neg-
ative fashion, resulting in their abnormally severe pheno-
types, because the predicted truncated product of the
genes as disrupted in the previous study is very long (571
amino acids), and Map1b571 heterozygotes whose level of
MAP1B expression remained at about half of the level of
controls have more severe neuronal abnormalities than
R21 homozygotes. On the other hand, our findings suggest
that MAP1B plays an important role in neuronal morpho-
genesis in cooperation with other neuronal MAPs, repre-
senting a MAP1B loss of function effect.
 
Materials and Methods
 
Construction of MAP1B Targeting Vector
 
For disruption of the endogenous MAP1B gene, a replacement-type tar-
geting vector was constructed (Fig. 1 
 
A
 
). A SalI-SalI fragment (13.5 kb)
containing the first coding exon of the MAP1B gene was obtained from
the 129/Sv mouse genomic library and subcloned into pBluescript II. Part
of the genomic sequence of the clone was confirmed to be identical to the
sequence of MAP1B cDNA (Noble et al., 1989). The PGK-neo gene was
ligated between the XhoI site introduced into the first coding exon by mu-
tagenesis using PCR and a HindIII site downstream of the first coding
exon. The PGK-tk gene was ligated into the upstream polylinker site.
 
Targeting the MAP1B Gene in ES Cells
 
Linearized vector-1 was electroporated into cultured J1 cells, and trans-
formants were selected using G418 and FIAU as described elsewhere
(Harada et al., 1994). The G418- and FIAU-resistant colonies were ex-
panded into cell lines, and genomic DNA was isolated for Southern blot-
ting. Homologous recombination was detected using BamHI with a
“probe,” a genomic region that was not included in the recombination
constructs, and then confirmed using EcoRI digestion (Fig. 1 
 
A
 
) for detec-
tion of the presence of a mutated MAP1B gene. In addition, neo-probe
was used for hybridization, and single bands that migrated to the expected
positions were observed in lanes loaded with genomic DNA isolated from
homologous recombinants.
 
Genotyping of Animals
 
Two separate allele-specific PCRs were performed for each animal. The
following primers were synthesized and used for the PCRs: primer 1, 5
 
9
 
-
ACACTTCTCTCAGGCTTGAGCAGAGCCG-3
 
9
 
; primer 2, 5
 
9
 
-ACG-
ATCGGATCCCCAGCTCGATGTTG-3
 
9
 
; and primer 3, 5
 
9
 
-GCTAAA-
GCGCATGCTCCAGACTGCCTTG-3
 
9
 
. The product amplified using
primers 1 and 2 was generated from the wild-type allele, whereas the
product amplified using primers 1 and 3 was generated from the mutated
allele (Fig. 1 
 
A
 
). DNA samples were prepared by incubating tails of ani-
mals in PCR buffer containing 50 mM KCl, 15 mM Tris-Cl, pH 8.3, 2.5
mM MgCl
 
2
 
, 0.5% Tween 20, and 100 
 
m
 
g/ml proteinase K at 55
 
8
 
C for 1 h,
followed by inactivation of the proteinase K at 95
 
8
 
C for 10 min. PCR am-
plifications consisted of denaturation at 94
 
8
 
C (30 s), annealing at 65
 
8
 
C (30
s), and extension at 72
 
8
 
C (30 s) for 35 cycles, in a reaction buffer contain-
ing 10 mM Tris-Cl, pH 8.3, 50 mM KCl, 2.0 mM MgCl
 
2
 
, 200 
 
m
 
M each of
dATP, dCTP, dGTP, and dTTP, 1 
 
m
 
M each of PCR primers, and 1 U of Taq
DNA polymerase (Perkin-Elmer Corp., Norwalk, CT). An aliquot of each
PCR mixture was analyzed by agarose gel electrophoresis.
 
Preparation of Crude Extracts and Immunoblotting
 
Crude extracts of whole brain were obtained as described previously
(Takei et al., 1995). Equal amounts of crude extracts were separated by
PAGE. Proteins were then electrophoretically transferred to nylon filters
(Millipore Corp., Bedford, MA). The nylon filters with transferred pro-
teins were blocked with 2% skim milk in TBS, incubated with mAbs or
polyclonal antisera for 1 h, and then rinsed in TBS containing 0.05%
Tween 20. In the case of the polyclonal antisera, mouse anti–rabbit IgG
was reacted with primary Abs. Finally, the nylon filters were incubated
with 
 
125
 
I-labeled protein A. Binding was detected and quantified by auto-
radiography using an imaging analyzer (model BAS-2000; Fuji Film, To-
kyo, Japan). The signals were normalized for the signal obtained with an
anti–NF-M Ab as an internal control. For the primary Abs, the following
mAbs or polyclonal antisera were used: 3d2 and YXY (Noble et al., 1989;
kindly provided by N.J. Cowan, New York University Medical Center) for
MAP1B; tau-1 (Boehringer Mannheim Corp., Indianapolis, IN), anti–human
tau, and 5E2 (kindly provided by Y. Ihara, University of Tokyo) for tau; HM2
(Sigma Chemical Co., St. Louis, MO) for MAP2; 1D1 (Shiomura and Hi-
rokawa, 1987
 
a
 
) for MAP1A; and NN18 (Sigma Chemical Co.) for NF-M.
 
Histological and Anatomical Analysis
 
Mice matched by age were anesthetized with ether and fixed in 4%
paraformaldehyde. Fixed brain tissues were embedded in paraffin, sec-
tioned, and stained with hematoxylin-eosin.
For immunocytochemical analysis, mice anesthetized with ether were
perfused with 2% paraformaldehyde and 0.1% glutaraldehyde in phos-
phate buffer. Various parts of the brains (cerebellum, hippocampus, olfac-
tory bulb, spinal cord, and retina) were dissected out and stored in the
same fixative overnight at 4
 
8
 
C. The procedure for cryoprotection, freez-
ing, and sectioning was previously described (Harada et al., 1990). After
preincubation in PBS containing glycine to quench aldehydes, followed by
5% skim milk in PBS, the sections were allowed to react with the primary
Abs followed by the secondary Abs (rhodamine-conjugated goat anti–
mouse or anti–rabbit IgG).
 
Conventional Electron Microscopy and
Morphometric Analysis
 
Mice matched by age were perfused with 2% paraformaldehyde and 2.5%
glutaraldehyde in 0.1 M cacodylate buffer. Tissues were dissected out and
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fixed overnight, processed for the conventional EM, and viewed under an
electron microscope (model 1200EX; JEOL U.S.A., Peabody, MA) at 100
kV. Matching areas of each tissue were examined and photographed, and
then the numbers of axons with compacted myelin sheaths were directly
counted from prints without preknowledge of genotypes. The diameters
of both myelinated and unmyelinated axons were also measured. The
numbers of myelinated axons were then converted to densities of myeli-
nated axons by dividing the counts by areas excluding glial cells and blood
vessels. In the same way, the MT numbers were counted and then con-
verted to MT densities by dividing the MT count by the area of each axon.
 
Results
 
Generation of Mice with Disrupted MAP1B Gene
 
The analysis of G418-resistant ES clones revealed a target-
ing frequency of 
 
z
 
1/250. ES cells carrying the mutated
MAP1B gene were injected into C57BL/6 embryos at the
blastocyst stage, and the embryos were then transferred
into the uteri of pseudopregnant recipients. The embryos
injected with R21 cell line developed into chimeric mice
transmitting the ES cell genome through the germ line, as
indicated by the agouti coat color of the offspring of mat-
ings of the chimeric mice with C57BL/6 females. Approxi-
mately 50% of these agouti pups were heterozygous for
the mutant MAP1B allele as determined by PCR and
Southern blot analysis (data not shown). These mice were
indistinguishable from their wild-type littermates and dis-
played no discernible abnormalities. To investigate the
phenotype of homozygous mutant mice, we interbred het-
erozygous mutant mice and genotyped the offspring (Fig.
1 
 
B
 
). The predicted 1:2:1 Mendelian distribution of wild-
type (MAP1B
 
1
 
/
 
1
 
), heterozygous mutant (MAP1B
 
1
 
/
 
2
 
),
and homozygous mutant (MAP1B
 
2
 
/
 
2
 
) animals was found.
A schematic direct comparison of our targeting strategy
with that of Edelmann et al. (1996) is presented in Fig. 2.
The predicted truncated product of the genes as disrupted
by us is 11 amino acids long (Fig. 2 
 
C
 
), whereas that of the
genes disrupted by Edelmann et al. (1996) is 571 amino ac-
ids long (Fig. 2 
 
B
 
).
 
General Observations
 
MAP1B
 
1
 
/
 
2
 
 mice grew with no apparent abnormalities in
a normal cage environment. Their bodies and entire brains
developed and reached normal weight (Tables I and II).
Their behavior could not be distinguished from that of
MAP1B
 
1
 
/
 
1
 
 littermates. On the other hand, the bodies
and mature whole brains of the MAP1B
 
2
 
/
 
2
 
 mice were
significantly smaller than those of the MAP1B
 
1
 
/
 
1
 
 mice
(Tables I and II). However, severe motor dysfunctions re-
ported by Edelmann et al. (1996), such as gait ataxia, spas-
tic tremor, and limb paralysis, were not observed in our
MAP1B
 
2
 
/
 
2
 
 mice. Their eyes often looked a little smaller
than those of the wild-type mice, possibly because of slight
drooping of their upper eyelids and retraction of their eye-
balls (blepharoptosis-like symptom). We confirmed that
the size of their eyeballs was within the normal range.
More than half of the MAP1B
 
2
 
/
 
2
 
 mice exhibited this symp-
tom unilaterally or bilaterally (Table III). Since Edelmann
Figure 1. Targeted disrup-
tion of the MAP1B gene in
ES cells and mice. (A) Tar-
geting strategy: Wild-type al-
lele containing the first cod-
ing exon of the MAP1B
gene, replacement-type tar-
geting vector, and targeted
allele after homologous re-
combination are shown. P1,
primer 1; P2, primer 2; P3,
primer 3; B, BamHI; E,
EcoRI; H, HindIII. Bar, 1 kb.
(B) Genotype of F2 mice of
R21 line. Tail DNA was iso-
lated and analyzed by South-
ern blotting using the 59-
flanking probe (A, probe) af-
ter digestion with BamHI.
Lane 1, MAP1B2/2 mouse;
lane 2, MAP1B1/2 mouse;
lane 3, MAP1B1/1 mouse.
WT, wild-type band; HR, ho-
mologous recombinant band.
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et al. (1996) reported that mice heterozygous for a dis-
rupted MAP1B gene lacked visual acuity, we subjected
adult mutant mice to a Morris swimming navigation test with
visible cues (Morris, 1981) to determine whether they had
visual acuity. MAP1B
 
2
 
/
 
2
 
 mice with the blepharoptosis-
like symptom could find the platform using the visual cues,
and their levels of performance did not differ from those
of MAP1B
 
1
 
/
 
1
 
 mice (data not shown); therefore, we con-
cluded that they are not blind. Only a small number of
MAP1B
 
2
 
/
 
2
 
 mice (
 
,
 
5% of the total number of MAP1B
 
2
 
/
 
2
 
mice) did not gain weight and died before reaching 3 wk of
age. However, once the MAP1B
 
2
 
/
 
2
 
 mice reached adult-
hood, they showed no evidence of premature mortality.
 
Expression of Cytoskeletal Proteins in MAP1B
 
2
 
/
 
2
 
 
Mutant Mice
 
For examination of the effect of the disruption of the
MAP1B gene, crude extracts were prepared from whole
brain (cerebrum and cerebellum) and examined by immu-
noblotting with anti-MAP1B antisera 3d2 and YXY (No-
ble et al., 1989; kindly provided by N.J. Cowan), and anti-
MAP1B mAb 1B6 (Sato-Yoshitake et al., 1989). 3d2 and
YXY recognize the entire MAP1B population, while 1B6
reacts only with phosphorylated MAP1B. 3d2 reacts with
repeat motifs near the NH
 
2
 
 terminus, which is responsible
for the interaction between MAP1B and MTs, and YXY
reacts with COOH-terminal–imperfect repeats (Fig. 2 
 
A
 
).
Abs stained very faintly a band of protein at a position
slightly below that of MAP1B in MAP1B
 
2
 
/
 
2
 
 crude brain
extract blots (Fig. 3, 
 
A
 
 and 
 
B
 
). We quantified this faint
band using 3d2 and YXY. The amount of this faint immu-
noreactivity in MAP1B
 
2
 
/
 
2
 
 brain is equivalent to 0–5% of
that in MAP1B
 
1
 
/
 
1
 
 brain at postnatal days 4, 8, and 14
and postnatal week 15. This residual signal may be derived
from a peptide different from the authentic MAP1B pro-
tein or a previously unknown alternatively spliced form.
It has been suggested that a functional redundancy
might exist among MAPs (Harada et al., 1994; DiTella et al.,
1996). We measured the relative amounts of other MAPs
in MAP1B
 
2
 
/
 
2
 
 brains compared with those in MAP1B
 
1
 
/
 
1
 
brains to investigate whether other MAPs are upregulated
to compensate for the loss of functions of MAP1B. How-
ever, in postnatal day 4 and adult brains, the amounts of
tau, MAP2 (a and b), and MAP1A did not differ between
MAP1B
 
2
 
/2 and 1/1 mice (Fig. 3, C–E).
Figure 2. Comparison of our
gene disruption strategy
with that used by Edelmann
et al. (1996). (A) MAP1B
polyprotein. 3d2 and YXY,
the regions to which two rab-
bit anti-MAP1B antisera
bind, are shown. LCBS, light
chain binding site; MTBD,
microtubule-binding do-
main; CTIR, COOH-termi-
nal imperfect repeats; LC1,
light chain 1; AA, amino ac-
ids. (B) Predicted truncated
product of the gene as dis-
rupted by Edelmann et al.
(1996). (C) Predicted trun-
cated product of the gene as
disrupted by us.
Table I. Body Weight of Mutant Mice and Wild-Type Controls
Age* Sex
Mean weights 6 SD (number of mice examined)
Wild-type Heterozygote Homozygote
g
8 d 5.1 6 0.8 (28) 4.8 6 0.9 (28) 3.7 6 0.7 (17)‡
8 wk male 23.9 6 2.7 (7) 25.0 6 2.8 (18) 20.1 6 2.6 (7)§
female 19.2 6 1.4 (13) 19.4 6 2.5 (21) 16.0 6 3.0 (7)§
12 wk male 26.9 6 3.2 (7) 28.2 6 3.8 (18) 21.2 6 2.2 (7)i
female 22.0 6 1.8 (10) 21.4 6 2.9 (20) 17.9 6 2.7 (5)§
*Number of postnatal days or weeks at time of measurements.
‡Different from value for wild-type mice at P , 0.000001, at P , 0.05,§ and at P ,
0.005.i  
Student’s t test was used to determine the significance of the difference.
Table II. Brain Weight of Mutant Mice and Wild-Type Controls
Genotype Weight (n)* Age‡
g
Wild-type 0.48 6 0.02 (6) 137 6 21
Heterozygote 0.47 6 0.03 (12) 136 6 22
Homozygote 0.41 6 0.02 (7)§ 136 6 21
*Weight of whole brain (cerebrum 1 cerebellum). The means 6 SD and n (the num-
ber of mice examined) are shown.
‡Number of postnatal days at time of sacrifice for experiments.
§Different from value for wild-type mice at P , 0.001; Student’s t test was used to de-
termine the significance of the difference.
Table III. Blepharoptosis-like Symptom in MAP1B2/2 Mice
Symptom n*
Bilateral 3
Unilateral 3
No symptom 2
Total 8
*Number of mice examined
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Brain Architecture in the Mutant Mice
It has been speculated that MAP1B plays important roles
in neuronal morphogenesis, especially in neurite extension
(Brugg et al., 1993; Ulloa et al., 1993; Avila et al., 1994). In
fact, Map1b571 heterozygotes have histological abnormal-
ities in the cerebellum, olfactory bulb, hippocampus, and
retina (Edelmann et al., 1996). To assess possible struc-
tural defects in the nervous system of MAP1B mutants, we
examined tissue sections by light microscopy. The general
structure of the MAP1B2/2 mutant brains appeared nor-
mal in hematoxylin-eosin sections except that the size of
the entire brains was slightly reduced (Table II). To com-
pare the localizations of cytoskeletal proteins in mutant and
control mice, we stained frozen sections of cerebellum from
postnatal day 8 and adult brains with Abs against cytoskel-
etal proteins. The staining intensity with the anti-MAP1B
antiserum YXY was much weaker in mutant sections than
Figure 3. Immunoblot analy-
sis of crude extracts of brain
with the anti-MAP1B antise-
rum 3d2 (A), with the anti-
MAP1B mAb 1B6 (B), with
the anti-MAP2 mAb HM2
(C), with the anti-tau mAb
tau-1 (D), and with the anti-
MAP1A mAb 1D1 (E). (A
and B) Lane 1, MAP1B1/1
brain at postnatal day 4; lane
2, MAP1B2/2 mutant brain
at postnatal day 4; lane 3,
MAP1B1/1 brain at post-
natal week 8; lane 4: MAP-
1B2/2 brain at postnatal
week 8. NF-M, neurofila-
ment M. (C–E) Lane 1,
MAP1B1/1 brain at postna-
tal week 8; lane 2, MAP-
1B2/2 brain at postnatal
week 8.
Figure 4. (A and B) Immu-
nofluorescence micrographs
of adult cerebellum. Sagittal
cryosections of cerebellar ver-
mis of MAP1B1/1 (A) and
2/2 (B) mice were stained
with anti-MAP1A mAb 1D1.
(C and D) Paraffin sections of
retinae of MAP1B1/1 (C)
and 2/2 (D) mice stained
with hematoxylin-eosin are
shown. There are no mor-
phological differences be-
tween the MAP1B1/1 and
2/2 tissues.
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in control sections, while we found no difference between
mutant and control sections in the staining pattern and in-
tensity with anti-MAP1A, anti-MAP2, or anti-tau. The den-
dritic arborization and the shape of the somata of cerebel-
lar Purkinje cells were within the normal ranges (Fig. 4, A
and B). We examined other brain structures, i.e., the hip-
pocampus, retina (Fig. 4, C and D), olfactory bulb, and spi-
nal cord, of postnatal day 8 and adult brains immunohis-
tochemically but found no abnormalities in the structure
of the MAP1B2/2 nervous system.
Delayed Myelination of MAP1B2/2 Nervous System
We focused on two representative structures in which
MAP1B is expressed at high levels, the developing optic
nerve and spinal cord (Tucker and Matus, 1987, 1988;
Tucker et al., 1988; Bates et al., 1993; Oudega et al., 1995).
We observed axons in optic nerves and anterior pyramidal
tracts by EM and performed morphometric analyses.
Since in the rodent optic nerve the ensheathment of axons
occurs in a rostro-caudal gradient, that is, from eye to op-
tic chiasm (Skoff et al., 1980), we set three levels (A, B,
and C) along the optic-nerve axis (Fig. 5 A). At postnatal
day 8, the densities of axons with compacted myelin
sheaths were significantly decreased in sections of MAP1B2/2
optic nerves (Figs. 5 B and 6, A and B) and spinal cords
(Fig. 7 A). In the wild-type optic nerves, the level of myeli-
nation exhibited an overt rostro-caudal gradient as ex-
pected, but no such gradient was apparent in the
MAP1B2/2 optic nerves (Fig. 5 B). Next, we observed
axons of adult MAP1B2/2 mice. The densities of axons
with compacted myelin sheaths did not differ between the
adult MAP1B2/2 and 1/1 mice in optic nerve sections
(Figs. 5, C and D and 8, A and B) and in spinal cord sec-
tions (Fig. 7 B). We concluded that the myelination of
MAP1B2/2 axons in optic nerves and anterior pyramidal
tracts of spinal cords was significantly delayed at postnatal
day 8, but caught up with wild-type myelination during de-
Figure 5. (A and C) Schematic illustra-
tions of optic nerve at postnatal day 8
(A) and postnatal week 8–14 (C), show-
ing levels A, B, C, and D, at which ul-
trathin sections were taken for EM
analysis. Each level was determined by
the distance from the optic chiasm. (B
and D) Quantitative comparison of the
numbers of myelinated axons per unit
area in juvenile (B) and adult (D) optic
nerves of MAP1B1/1 and 2/2 mice.
Solid bars represent each value (per
102 mm2) for the optic nerve of a
MAP1B1/1 mouse. Open bars repre-
sent each value (per 102 mm2) for the
optic nerve of a MAP1B2/2 mouse.
PD, postnatal days; PW, postnatal
weeks.
 o
n
 August 12, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published June 30, 1997
Takei et al. Disruption of MAP1B Gene 1621
velopment and was almost complete in the adult mice. We
found no difference in the level of myelination between
MAP1B2/2 and 1/1 trigeminal and sciatic nerves at post-
natal day 8 (data not shown).
Axonal Diameters in MAP1B2/2 Optic Nerve
To assess whether axonal maturation is delayed in MAP1B2/2
neurons, we measured diameters of MAP1B2/2 axons in
sections of juvenile and adult optic nerves. At postnatal
Figure 6. Electron micrographs
showing representative areas of
cross sections of optic nerves of
MAP1B1/1 (A) and 2/2 (B)
mice at postnatal day 8. Axons
in the MAP1B2/2 optic nerve
(B) are less myelinated than
those in the MAP1B1/1 optic
nerve (A). Bar, 2 mm.
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day 8, the diameters of axons were significantly decreased
in MAP1B2/2 sections (Fig. 9 A). However, the axonal
diameter did not differ between MAP1B2/2 and 1/1 op-
tic nerves at postnatal week 8 (Fig. 9 B, P .0.6; Student’s t
test). This indicates that axonal maturation was delayed in
MAP1B2/2 optic nerves, but caught up with that in wild-
type optic nerves during development.
MT Density in MAP1B2/2 Axons
MAP1B has been postulated to regulate MT dynamics via
an MT-stabilizing effect in cooperation with MAP2, tau,
and MAP1A (Takemura et al., 1992). In mice lacking tau,
neurons exhibit neurite elongation but decreased densities
of MTs in small-caliber axons (Harada et al., 1994). This
decreased MT density has been attributed to the loss of an
MT-stabilizing effect of tau, though neurons lacking tau
show axon elongation, possibly because of compensation
by other MAPs for the loss of tau functions.
To assess whether the disruption of the MAP1B gene af-
fects MT stability, we performed morphometric analysis of
three representative structures: olfactory sensory neurons,
in which MAP1B is strongly expressed even in the adult
nervous system (Tucker et al., 1989; Viereck et al., 1989),
the optic nerve, and cerebellar parallel fibers. No signifi-
cant reduction of MT number and density was observed in
MAP1B2/2 axons of each area (Table IV).
Discussion
Delayed Development of MAP1B2/2 Nervous System
MAP1B is one of the early MAPs expressed mainly in the
nervous system (Tanaka et al., 1992; Avila et al., 1994). It
had been postulated that MAP1B is involved in neuronal
morphogenesis (Brugg et al., 1993; Ulloa et al., 1993; Avila
et al., 1994). However, little is known about its physiologi-
cal function. To define its role in vivo, we generated a mu-
tant mouse line with a disrupted MAP1B gene. Though
the weight of the MAP1B2/2 brains was slightly reduced,
their structures were not significantly different from those
of MAP1B1/1 brains at the light microscopic level. EM
analysis revealed that myelination and axon caliber expan-
sion were delayed in developing MAP1B2/2 optic nerves.
However, we found no morphological differences between
adult MAP1B1/1 and 2/2 optic nerve sections. These find-
ings indicate that the development of the MAP1B2/2
optic nerves was not completely inhibited by the disrup-
tion of the MAP1B gene, but delayed, and then caught up
with that of the wild-type optic nerves. The same pattern
of delayed myelination as found in MAP1B2/2 optic
nerve axons was observed in MAP1B2/2 pyramidal tract
axons.
What is the basis for this delay? The most plausible pos-
sibility is that MAP1B deficiency caused delayed axonal
development, which would result in retardation of myeli-
nation because neurons associate specifically with oligo-
dendrocytes and influence their development and differ-
entiation via soluble factors (Collarini et al., 1991). This
hypothesis is consistent with the aforementioned reports
suggesting an important role of MAP1B in neuronal mor-
phogenesis. Another possibility is that oligodendrocytes
themselves did not develop normally because of a lack of
MAP1B. A considerable amount of MAP1B is normally
expressed in oligodendrocytes (Fischer et al., 1990; Vou-
yiouklis and Brophy, 1993; Ulloa et al., 1994). Further-
more, MAP1B expression is first detected in cultured glial
progenitor cells immediately before they differentiate into
complex process-bearing oligodendrocytes (Vouyiouklis
and Brophy, 1993), suggesting that MAP1B might have a
role in the formation of myelin-forming processes. There-
fore, it is plausible that lack of MAP1B directly affects oli-
godendrocyte development, resulting in delayed myelina-
tion, which can disturb neuronal/axonal development.
Since these two possibilities are compatible with each
other, both mechanisms could be involved in the observed
developmental delay of the MAP1B2/2 nervous system.
On the other hand, why was the delayed myelination not
observed in MAP1B2/2 sciatic and trigeminal nerves at
postnatal day 8? A possible explanation is that the myeli-
nation of the MAP1B2/2 sciatic and trigeminal nerves
had already caught up with that of the wild-type ones by
the time of sacrifice of the mice. In rodents, myelination
begins, peaks, and declines to a basal level at an earlier age
in the peripheral nervous system than in the central ner-
vous system (Stahl et al., 1990), which supports this hy-
pothesis. A second possibility is that the degree of the
effect of MAP1B gene disruption differs between oligo-
dendrocytes and Schwann cells. However, no data sup-
porting this hypothesis are available.
Density of MTs in MAP1B2/2 Mice
In a previous study, we found a decreased number and
density of MTs in cerebellar parallel fibers of tau-deficient
mice, which could be attributed to loss of a MT-stabilizing
effect of tau (Harada et al., 1994). The decrease in the den-
sity of MTs in the tau-deficient mice was specific to cere-
Figure 7. Quantitative comparison of the numbers of myelinated
axons (per 102 mm2) in juvenile (A) and adult (B) anterior pyra-
midal tract axons of MAP1B1/1 and 2/2 spinal cords. Solid
bars represent each value (per 102 mm2) for the spinal cord of a
MAP1B1/1 mouse. Open bars represent each value (per 102
mm2) for the spinal cord of a MAP1B2/2 mouse. PD, postnatal
days; PW, postnatal weeks.
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bellar small-caliber axons. Since in these axons tau ac-
counts for a large proportion of the total MAPs, the loss of
tau in these axons is considered to affect strongly the sta-
bility of MTs in these axons. However, disruption of the
MAP1B gene resulted in no change in the density of MTs
in the axons. Differences between MAP1B and other
MAPs in regard to interactions with MTs might explain
this difference in phenotypes between tau and MAP1B
knock-out mice. First, in vitro assembly of MTs mediated
by MAP1B is not as efficient as that mediated by other
neuronal MAPs (Bloom et al., 1985). Second, the MTs in
fibroblasts transfected with MAP1B cDNA are less stable
to the effects of an MT-depolymerization reagent than
those in fibroblasts transfected with MAP2c or tau cDNA,
with no extensive reorganization of MTs such as bundle
formation, which is seen in fibroblasts transfected with tau
Figure 8. Electron micrographs
showing representative areas of
cross sections of optic nerves of
MAP1B1/1 (A) and 2/2 (B) mice
at postnatal week 14. There are no
differences in the number of myeli-
nated axons per unit area, diameter
of axons, thickness of myelin
sheaths, and density of MTs. Bar,
500 nm.
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or MAP2c cDNA (Takemura et al., 1992). The fact that
the MT density was unchanged in the MAP1B2/2 axons
might have been due to the weakness of the interaction of
MAP1B with MTs. However, double knock-out mice gen-
erated by intercrossing tau and MAP1B knock-out mice
exhibited decreased MT densities in the optic nerve and
olfactory bulb (Inomata, S., unpublished observation).
This suggests that disruption of the MAP1B gene en-
hances the effect of disruption of the tau locus to reduce
the density of MTs. Taken together with a recent report
that MAP1B and tau can be functionally substituted for
each other in laminin-enhanced axonal growth of cultured
cerebellar macroneurons (DiTella et al., 1996), it is plausi-
ble that MAP1B functions to stabilize neuronal MTs in co-
operation with other MAPs.
Phenotypes of MAP1B2/2 Mutants
The phenotypes of our MAP1B mutants (R21 mutant
mice) are very different from those of Map1b571 mutant
mice (Edelmann et al., 1996), mainly in the following
points: (a) Map1b571 heterozygotes showed severe neu-
ronal abnormalities, but R21 heterozygotes appeared
healthy. (b) Map1b571 homozygous mutant embryos were
Figure 9. Quantitative com-
parison of the axonal diame-
ters in juvenile (A) and adult
(B) optic nerves of
MAP1B1/1 and 2/2 mice.
Solid bars represent mean
values 6 SD (mm) for axons
in a MAP1B1/1 mouse.
Open bars represent mean
values 6 SD (mm) for axons
in a MAP1B 2/2 mouse.
*Different from value for
controls at P , 0.0005, ** at
P , 1028, and *** at P ,
10211. Student’s t test was
used to determine the signifi-
cance of the differences. Lev-
els A, B, C, and D are deter-
mined in the same way as
described in Fig. 5 legend.
PD, postnatal days; PW,
postnatal weeks. n, the num-
ber of axons examined.
Table IV. MT Density in MAP1B1/1 and 2/2 Axons
Examined area Number and genotype of samples Age* Area of examined axons MT density‡ (n)
1022 mm2
Cerebellar parallel fiber Wild-type 8 24 0.020 6 0.010 1.2 6 0.5 (49)
Homozygote 9 24 0.021 6 0.006 1.2 6 0.4 (31)
Optic nerve Wild-type 9 8 0.32 6 0.12 0.6 6 0.2 (26)
Wild-type 10 8 0.30 6 0.11 0.7 6 0.2 (35)
Homozygote 10 8 0.34 6 0.11 0.7 6 0.1 (30)
Homozygote 11 8 0.31 6 0.13 0.7 6 0.2 (28)
Olfactory sensory neuron Wild-type 11 7 0.022 6 0.006 1.3 6 0.4 (27)
(near the surface) Homozygote 12 7 0.023 6 0.005 1.3 6 0.4 (22)
Olfactory sensory neuron Wild-type 12 7 0.033 6 0.007 0.8 6 0.3 (26)
(near the glomerular Wild-type 13 8 0.034 6 0.007 1.2 6 0.5 (10)
layer) Wild-type 14 8 0.035 6 0.014 1.1 6 0.4 (16)
Homozygote 13 7 0.037 6 0.006 0.8 6 0.2 (25)
Homozygote 14 8 0.036 6 0.014 1.0 6 0.4 (26)
Homozygote 15 8 0.037 6 0.006 1.2 6 0.3 (20)
The means 6 SD and n (the number of axons examined) are shown. In each examined area, MT density did not differ significantly between MAP1B1/1 and 2/2 mice.
*Number of postnatal weeks at time of sacrifice for experiments.
‡Number of MTs per 1022 mm2.
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nonviable, but R21 homozygotes reached adulthood. Gen-
erally, Map1b571 mutant mice exhibited more severe
abnormalities than R21 mutant mice. This phenotypic
variation cannot be attributed to differences in genetic
background, as both R21 and Map1b571 mutant mice were
analyzed in the same hybrid C57BL/129 backgrounds.
Our targeting scheme and that of Edelmann et al. (1996)
differ most considerably in the design of the targeting vec-
tors; we inserted a selection cassette into the first coding
exon of the MAP1B gene, whereas Edelmann et al. (1996)
inserted it into a SpeI site 59 to the MT-binding domain of
the MAP1B gene (Fig. 2). It is reasonable to consider that
this difference in vector construction is at the basis of the
phenotypic variation. The predicted truncated product of
the gene as disrupted by Edelmann et al. (1996) is 571
amino acids long, whereas that of the gene as disrupted by
us is 11 amino acids long (Fig. 2, B and C). The pheno-
types of Map1b571 heterozygotes cannot be explained by
a simple loss of function of the MAP1B gene because
Map1b571 heterozygotes, in which the amount of MAP1B
remained at about half the amount in the wild-type mice,
have a more severe phenotype than do R21 homozygotes.
Therefore, the most plausible possibility is that Map1b571
mutant mice produce a long truncated peptide acting in a
dominant-negative fashion, resulting in their abnormally
severe phenotypes. By immunoblotting using an Ab spe-
cific for the NH2-terminal 150 amino acids of MAP1B,
Edelmann et al. (1996) have excluded the existence of this
long truncated product in their mutant mice, and they
speculated that this product is unstable. However, judging
from the pattern of the blottings they presented, they used
mature brain tissue for immunoblotting, not developing
brain tissue, though they did not clearly state the ages of
mice sacrificed for their experiments. Therefore, consider-
ing that MAP1B is strongly expressed in the developing
murine nervous system, the existence of such a long trun-
cated polypeptide in juvenile Map1b571 mutant brains
cannot be excluded. Moreover, the phenotypes of Map1b571
mutant mice seem to be too severe, since mice lacking an-
other major neuronal MAP, tau, resulted in only minimal
neuronal phenotypes (Harada et al., 1994), and even dou-
ble knock-out mice lacking both tau and MAP1B could
reach adulthood (unpublished observation). From the
above, we conclude that R21 mutant mice exhibit a true
loss of function phenotype of the MAP1B gene, whereas
the phenotypes of Map1b571 mutant mice are affected by
a long truncated product acting in a dominant-negative
fashion.
Another possibility is that “neighborhood phenotypic
effects” (Olson et al., 1996) might contribute to the differ-
ence in phenotypes between R21 and Map1b571 mutant
mice. This term refers to deletion of part of the target gene,
or insertion of a selection cassette, affecting the expression
of other genes located near the intended target, confound-
ing the interpretation of phenotypes. Several cases of this
effect mediating phenotypic variation due to mutations in-
troduced by gene targeting have been described (Olson
et al., 1996). In the case of myogenic regulatory factor 4,
different laboratories have generated knock-outs with dif-
ferent phenotypes, ranging from death at birth to survival
to adulthood (Olson et al., 1996). For determination of
whether this is the case with MAP1B knock-outs, details
of the structure of neighboring genes must be elucidated,
and mice with subtle mutations in the MAP1B gene, such
as an effectively positioned stop codon, must be gener-
ated.
From the above, we conclude that MAP1B plays an im-
portant role in neuronal development. However, the exact
functions of MAP1B in vivo remain obscure. Future analy-
sis of tau/MAP1B double mutant and primary neuronal
cultures derived from various mutants will enrich our un-
derstanding of the functions of MAPs.
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